glp 1 memory Glucagon-like peptide-1 medicines in neurological and psychiatric disorders: Cell Reports Medicine GLP-1 receptor agonists effect on
Description
10.1111/j.1365-3083.1989.tb01108.x 34
Early non-responders assigned to BT plus AOM achieved a mean percent reduction in randomized body weight of 5.9 0.7% from randomization to week 24
Many medications were approved, dosed, and studied primarily in men
Wilfley DE, Crow SJ, Hudson JI, Mitchell JE, Berkowitz RI, Blakesley V, Walsh BT, Sibutramine Binge Eating Disorder Research Group
doi: 10.1038/nm.4236 101 PsichasA.SleethM
Targeting GLP-1 receptors to reduce nicotine use disorder
